Skip to content
Wednesday, August 26, 2026
Women's Health Trial Tracker — 2016
| Record | Record Date | Vuga Group | Change Status | Recency Days | Public Significance Score |
|---|
| Ovarian Tissue Cryopreservation in Children | 01/05/2016 | INTERVENTIONAL | unchanged | 3,886.85 | 0 |
|---|
| Pain Control in Breast Surgery: Analgesia, Opioid Consumption and Inflammatory Response Evaluation | 01/06/2016 | INTERVENTIONAL | unchanged | 3,885.85 | 0 |
|---|
| Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation | 01/06/2016 | INTERVENTIONAL | unchanged | 3,885.85 | 0 |
|---|
| Acupuncture or Metformin for Insulin Resistance in Women With PCOS | 01/06/2016 | INTERVENTIONAL | unchanged | 3,885.85 | 0 |
|---|
| Reprometabolic Syndrome Mediates Subfertility in Obesity | 01/12/2016 | INTERVENTIONAL | unchanged | 3,879.85 | 0 |
|---|
| Women at Risk of Breast Cancer and OLFM4 | 01/12/2016 | INTERVENTIONAL | unchanged | 3,879.85 | 0 |
|---|
| Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) | 01/12/2016 | OBSERVATIONAL | unchanged | 3,879.85 | 0 |
|---|
| The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer | 01/12/2016 | INTERVENTIONAL | unchanged | 3,879.85 | 0 |
|---|
| A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy | 01/13/2016 | INTERVENTIONAL | unchanged | 3,878.85 | 0 |
|---|
| Uterine Transplantation and Pregnancy Induction in Women Affected by Absolute Uterine Infertility | 01/15/2016 | INTERVENTIONAL | unchanged | 3,876.85 | 0 |
|---|
| Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation | 01/20/2016 | INTERVENTIONAL | unchanged | 3,871.85 | 0 |
|---|
| Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | 01/20/2016 | INTERVENTIONAL | unchanged | 3,871.85 | 0 |
|---|
| Apical Suspension Repair for Vault Prolapse In a Three-Arm Randomized Trial Design | 02/09/2016 | INTERVENTIONAL | unchanged | 3,851.85 | 0 |
|---|
| Phase I Dose Escalation of Single Fraction Adjuvant Stereotactic Body Partial Breast Irradiation Early Stage Breast CA | 02/18/2016 | INTERVENTIONAL | unchanged | 3,842.85 | 0 |
|---|
| Vitamin D Dynamics in Women | 03/10/2016 | OBSERVATIONAL | unchanged | 3,821.85 | 0 |
|---|
| Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Severe Left Diaphragmatic Hernia (CDH) | 03/17/2016 | INTERVENTIONAL | unchanged | 3,814.85 | 0 |
|---|
| Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer | 03/18/2016 | INTERVENTIONAL | unchanged | 3,813.85 | 0 |
|---|
| A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction | 03/31/2016 | INTERVENTIONAL | unchanged | 3,800.85 | 0 |
|---|
| Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training | 04/04/2016 | INTERVENTIONAL | unchanged | 3,796.85 | 0 |
|---|
| Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur) | 04/04/2016 | INTERVENTIONAL | unchanged | 3,796.85 | 0 |
|---|
| MRI-Based Preoperative Accelerated Partial Breast Irradiation | 04/05/2016 | INTERVENTIONAL | unchanged | 3,795.85 | 0 |
|---|
| Standard Follow-up Program Cervix Cancer (SFP CERVIX) | 04/11/2016 | OBSERVATIONAL | unchanged | 3,789.85 | 0 |
|---|
| Zambian Preterm Birth Prevention Study | 04/14/2016 | OBSERVATIONAL | unchanged | 3,786.85 | 0 |
|---|
| Uterine Transplant in Absolute Uterine Infertility (AUIF) | 04/18/2016 | INTERVENTIONAL | unchanged | 3,782.85 | 0 |
|---|
| Lymphedema Surveillance Study | 04/19/2016 | OBSERVATIONAL | unchanged | 3,781.85 | 0 |
|---|
| DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer | 04/20/2016 | INTERVENTIONAL | unchanged | 3,780.85 | 0 |
|---|
| Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications | 04/20/2016 | OBSERVATIONAL | unchanged | 3,780.85 | 0 |
|---|
| A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer | 04/21/2016 | INTERVENTIONAL | unchanged | 3,779.85 | 0 |
|---|
| Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer | 04/25/2016 | INTERVENTIONAL | unchanged | 3,775.85 | 0 |
|---|
| Breast Cancer WEight Loss Study (BWEL Study) | 04/26/2016 | INTERVENTIONAL | unchanged | 3,774.85 | 0 |
|---|
| Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer | 04/27/2016 | INTERVENTIONAL | unchanged | 3,773.85 | 0 |
|---|
| Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment | 04/28/2016 | INTERVENTIONAL | unchanged | 3,772.85 | 0 |
|---|
| A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer | 04/28/2016 | INTERVENTIONAL | unchanged | 3,772.85 | 0 |
|---|
| Trial to Compare Radiation Fibrosis With Five Versus Three Fractions | 04/29/2016 | INTERVENTIONAL | unchanged | 3,771.85 | 0 |
|---|
| Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations | 05/04/2016 | INTERVENTIONAL | unchanged | 3,766.85 | 0 |
|---|
| A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer | 05/05/2016 | INTERVENTIONAL | unchanged | 3,765.85 | 0 |
|---|
| Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) | 05/06/2016 | INTERVENTIONAL | unchanged | 3,764.85 | 0 |
|---|
| Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients | 05/13/2016 | OBSERVATIONAL | unchanged | 3,757.85 | 0 |
|---|
| Gastroschisis Outcomes of Delivery (GOOD) Study | 05/17/2016 | INTERVENTIONAL | unchanged | 3,753.85 | 0 |
|---|
| Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers | 05/17/2016 | INTERVENTIONAL | unchanged | 3,753.85 | 0 |
|---|
| Apremilast Pregnancy Exposure Registry | 05/17/2016 | OBSERVATIONAL | unchanged | 3,753.85 | 0 |
|---|
| Clinical Performance of B-Lite® Light Weight Breast Implant | 05/19/2016 | INTERVENTIONAL | unchanged | 3,751.85 | 0 |
|---|
| Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer | 05/20/2016 | INTERVENTIONAL | unchanged | 3,750.85 | 0 |
|---|
| Evaluating the Effects of Genetic Testing on Patients' Stress Levels | 05/26/2016 | OBSERVATIONAL | unchanged | 3,744.85 | 0 |
|---|
| Understanding and Predicting Breast Cancer Events After Treatment | 06/07/2016 | INTERVENTIONAL | unchanged | 3,732.85 | 0 |
|---|
| T-Cell Therapy for Advanced Breast Cancer | 06/07/2016 | INTERVENTIONAL | unchanged | 3,732.85 | 0 |
|---|
| Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions | 06/16/2016 | INTERVENTIONAL | unchanged | 3,723.85 | 0 |
|---|
| BMI-based Vitamins in Obese Pregnant Women | 06/16/2016 | INTERVENTIONAL | unchanged | 3,723.85 | 0 |
|---|
| KOrean Borderline Ovarian Tumor (KOBOT) Registry | 06/17/2016 | OBSERVATIONAL | unchanged | 3,722.85 | 0 |
|---|
| Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia | 06/17/2016 | INTERVENTIONAL | unchanged | 3,722.85 | 0 |
|---|
| Ovarian Cancer Hemoscope Trial | 06/23/2016 | OBSERVATIONAL | unchanged | 3,716.85 | 0 |
|---|
| Dried Plums and Bone Health in Postmenopausal Women | 07/04/2016 | INTERVENTIONAL | unchanged | 3,705.85 | 0 |
|---|
| Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer | 07/11/2016 | INTERVENTIONAL | unchanged | 3,698.85 | 0 |
|---|
| Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer | 07/11/2016 | INTERVENTIONAL | unchanged | 3,698.85 | 0 |
|---|
| Trial on Radical Upfront Surgery in Advanced Ovarian Cancer | 07/11/2016 | INTERVENTIONAL | unchanged | 3,698.85 | 0 |
|---|
| Observational Study on Endometrial Stromal Tumors | 07/12/2016 | OBSERVATIONAL | unchanged | 3,697.85 | 0 |
|---|
| A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls | 07/15/2016 | INTERVENTIONAL | unchanged | 3,694.85 | 0 |
|---|
| Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | 07/21/2016 | INTERVENTIONAL | unchanged | 3,688.85 | 0 |
|---|
| Advanced Fetal Imaging - Phase II | 07/21/2016 | INTERVENTIONAL | unchanged | 3,688.85 | 0 |
|---|
| Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) | 08/08/2016 | INTERVENTIONAL | unchanged | 3,670.85 | 0 |
|---|
| Institut Paoli Calmettes Cervical Cancer Database | 08/17/2016 | OBSERVATIONAL | unchanged | 3,661.85 | 0 |
|---|
| Institut Paoli Calmettes Ovarian Cancer Database | 08/17/2016 | OBSERVATIONAL | unchanged | 3,661.85 | 0 |
|---|
| Bladder Directed vs. Pelvic Floor Therapy in IC/BPS | 08/17/2016 | INTERVENTIONAL | unchanged | 3,661.85 | 0 |
|---|
| Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation | 08/18/2016 | INTERVENTIONAL | unchanged | 3,660.85 | 0 |
|---|
| Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS) | 08/18/2016 | INTERVENTIONAL | unchanged | 3,660.85 | 0 |
|---|
| A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib | 08/22/2016 | INTERVENTIONAL | unchanged | 3,656.85 | 0 |
|---|
| Use of a Squatting Assist Device in Patients With Constipation | 08/24/2016 | INTERVENTIONAL | unchanged | 3,654.85 | 0 |
|---|
| Fertility Preservation in Young Women With Cancer | 08/25/2016 | OBSERVATIONAL | unchanged | 3,653.85 | 0 |
|---|
| Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer | 08/30/2016 | INTERVENTIONAL | unchanged | 3,648.85 | 0 |
|---|
| Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery | 08/31/2016 | INTERVENTIONAL | unchanged | 3,647.85 | 0 |
|---|
| Hong Kong Breast Cancer Study | 09/05/2016 | OBSERVATIONAL | unchanged | 3,642.85 | 0 |
|---|
| EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer | 09/07/2016 | INTERVENTIONAL | unchanged | 3,640.85 | 0 |
|---|
| Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer | 09/07/2016 | INTERVENTIONAL | unchanged | 3,640.85 | 0 |
|---|
| Persistent Organic Pollutants and Breast Cancers (POPCASE) | 09/07/2016 | INTERVENTIONAL | unchanged | 3,640.85 | 0 |
|---|
| The French National Reference Centre of GTD | 09/08/2016 | OBSERVATIONAL | unchanged | 3,639.85 | 0 |
|---|
| Bergonie Institute Breast Cancer Database | 09/08/2016 | OBSERVATIONAL | unchanged | 3,639.85 | 0 |
|---|
| PREgnancy and FERtility Registry | 09/09/2016 | OBSERVATIONAL | unchanged | 3,638.85 | 0 |
|---|
| Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome | 09/12/2016 | OBSERVATIONAL | unchanged | 3,635.85 | 0 |
|---|
| A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast | 09/13/2016 | INTERVENTIONAL | unchanged | 3,634.85 | 0 |
|---|
| Vaginal and Oral Microbiome Crosstalk | 09/13/2016 | OBSERVATIONAL | unchanged | 3,634.85 | 0 |
|---|
| Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer | 09/23/2016 | INTERVENTIONAL | unchanged | 3,624.85 | 0 |
|---|
| Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer | 09/23/2016 | INTERVENTIONAL | unchanged | 3,624.85 | 0 |
|---|
| Accelerated Radiation Therapy (ART) to the Breast and Nodal Stations | 09/28/2016 | INTERVENTIONAL | unchanged | 3,619.85 | 0 |
|---|
| Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes | 09/28/2016 | OBSERVATIONAL | unchanged | 3,619.85 | 0 |
|---|
| Predictors of De-novo Development of Obstructive Sleep Apnea in Pregnancy | 09/28/2016 | OBSERVATIONAL | unchanged | 3,619.85 | 0 |
|---|
| CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer | 09/28/2016 | INTERVENTIONAL | unchanged | 3,619.85 | 0 |
|---|
| Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer | 09/29/2016 | INTERVENTIONAL | unchanged | 3,618.85 | 0 |
|---|
| Memory Gel and Shape Combined Cohort | 09/29/2016 | INTERVENTIONAL | unchanged | 3,618.85 | 0 |
|---|
| Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy With Prior Spontaneous Preterm Birth | 10/05/2016 | INTERVENTIONAL | unchanged | 3,612.85 | 0 |
|---|
| Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy | 10/06/2016 | INTERVENTIONAL | unchanged | 3,611.85 | 0 |
|---|
| Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS | 10/06/2016 | INTERVENTIONAL | unchanged | 3,611.85 | 0 |
|---|
| Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction | 10/07/2016 | INTERVENTIONAL | unchanged | 3,610.85 | 0 |
|---|
| Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts | 10/14/2016 | INTERVENTIONAL | unchanged | 3,603.85 | 0 |
|---|
| Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer | 10/24/2016 | INTERVENTIONAL | unchanged | 3,593.85 | 0 |
|---|
| Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy | 10/26/2016 | INTERVENTIONAL | unchanged | 3,591.85 | 0 |
|---|
| Pregnancy Outcomes: Effects of Metformin Study (POEM Study) | 10/28/2016 | INTERVENTIONAL | unchanged | 3,589.85 | 0 |
|---|
| Impact of Complete Surgery of Colorectal Deep Infiltrating Endometriosis on Fertility | 10/31/2016 | INTERVENTIONAL | unchanged | 3,586.85 | 0 |
|---|
| Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer | 11/04/2016 | INTERVENTIONAL | unchanged | 3,582.85 | 0 |
|---|
| Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women. | 11/04/2016 | OBSERVATIONAL | unchanged | 3,582.85 | 0 |
|---|
| Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation | 11/08/2016 | INTERVENTIONAL | unchanged | 3,578.85 | 0 |
|---|
| Composite Outcomes of Mesh vs Suture Techniques for Prolapse Repair: A Randomized Controlled Multicentre Trial | 11/16/2016 | INTERVENTIONAL | unchanged | 3,570.85 | 0 |
|---|
| Trial of Maternal Oxygen for Fetal Left Heart Hypoplasia | 11/17/2016 | INTERVENTIONAL | unchanged | 3,569.85 | 0 |
|---|
| Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD | 11/23/2016 | OBSERVATIONAL | unchanged | 3,563.85 | 0 |
|---|
| Use of Sildenafil for Treatment of Urinary Incontinence | 12/06/2016 | INTERVENTIONAL | unchanged | 3,550.85 | 0 |
|---|
| Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia | 12/08/2016 | INTERVENTIONAL | unchanged | 3,548.85 | 0 |
|---|
| Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia | 12/12/2016 | INTERVENTIONAL | unchanged | 3,544.85 | 0 |
|---|
| Trial Evaluating Role of Post Mastectomy Radiotherapy in Women With Node Negative Early Breast Cancer | 12/14/2016 | INTERVENTIONAL | unchanged | 3,542.85 | 0 |
|---|
| Image-Guided Gynecologic Brachytherapy | 12/15/2016 | INTERVENTIONAL | unchanged | 3,541.85 | 0 |
|---|
| PPROM Registry (Preterm Premature Rupture of Membranes) | 12/20/2016 | OBSERVATIONAL | unchanged | 3,536.85 | 0 |
|---|
| Exercise Interventions for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy | 12/21/2016 | INTERVENTIONAL | unchanged | 3,535.85 | 0 |
|---|
| The prEgnanCy and eArly Childhood nutrItion triaL (ECAIL) | 12/26/2016 | INTERVENTIONAL | unchanged | 3,530.85 | 0 |
|---|